Patheon

Patheon files registration for Initial Public Offering

Wednesday, June 10, 2015

Patheon, a CRO based in Durham, N.C., has filed a registration statement with the Securities and Exchange Commission (SEC) relating to the proposed initial public offering of its common stock. The number of shares to be offered and the price range for the offering have not yet been determined.

[Read More]

DPx to expand facility in North Carolina, add 488 jobs

Thursday, October 9, 2014

DPx, the “umbrella name” for Patheon’s three business units specializing in pharmaceutical services, fine chemicals and proprietary products and technologies, will expand operations in Pitt County, N.C. The company plans to create 488 jobs in Greenville, N.C. by the end of 2019 and invest $159 million to increase the site’s capabilities, as well as modernize the site and develop energy efficiency programs at the facility.

[Read More]

Royal DSM, JLL create jointly owned CDMO

Wednesday, November 20, 2013

JLL Partners, a middle-market private equity firm, and Royal DSM, a global life sciences and materials sciences company, have created a new global contract development and manufacturing organization (CDMO) for the pharmaceutical industry, with anticipated sales of around $2 billion. It will be 51% owned by JLL and 49% owned by DSM.

[Read More]

Aesica appoints two business development managers

Monday, July 15, 2013

Aesica, a global contract development and manufacturing organization (CDMO), has appointed Sven Thomas and David Ross business development managers. They will ensure potential customers are aware of how their manufacturing and development needs can be supported.

[Read More]

Patheon increases investment in Milton Park, U.K. facility

Monday, February 4, 2013

Patheon, a provider of contract development and commercial manufacturing services, has announced plans for additional investment in its Milton Park facility. Located in Oxfordshire, U.K., Milton Park is a dedicated pharmaceutical development services facility focused on early development projects.

[Read More]

Patheon to acquire Banner Pharmacaps

Tuesday, October 30, 2012

Patheon, a Durham, N.C.-based provider of contract development and manufacturing services, has signed a definitive agreement with Vion, a global manufacturer of foodstuffs and ingredients based in the Netherlands, to acquire Banner Pharmacaps, a High Point, N.C.-based specialty pharmaceutical business dedicated to the research, development and manufacturing of unique gelatin-based dosage forms.

[Read More]